Evidence map›Paper›PMID 42669190›Full record

ArticleThe Prostate2026

Primary BPH Stromal Cell Cultures Exhibit Heightened Androgen-Responsiveness.

Wei Chen, Fulu Dong, Mohammad Reza Askarpour, Laura E Pascal, Rajiv Dhir, Uma Chandran, Bruce L Jacobs, Donald B DeFranco, Naoki Yoshimura, Zhou Wang

Abstract read
In one paragraph

Article in The Prostate, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Wei ChenDepartment of Urology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Fulu DongDepartment of Urology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.ORCID https://orcid.org/0000-0002-4714-7531
Mohammad Reza AskarpourDepartment of Urology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.ORCID https://orcid.org/0000-0001-5702-4036
Laura E PascalDepartment of Urology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.ORCID https://orcid.org/0000-0003-3840-1662
Rajiv DhirDepartment of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.ORCID https://orcid.org/0000-0001-6424-6112
Uma ChandranUPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Bruce L JacobsDepartment of Urology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Donald B DeFrancoDepartment of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.ORCID https://orcid.org/0000-0002-7662-4886
Naoki YoshimuraDepartment of Urology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.ORCID https://orcid.org/0000-0001-8070-1664
Zhou WangDepartment of Urology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.ORCID https://orcid.org/0000-0002-1604-4767

Funding

Role of E-Cadherin Down-Regulation in Prostatic Inflammation and Lower Urinary Tract DysfunctionR01DK134580 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Zhou Wang, NAOKI YOSHIMURA · 2023 to 2026
$2.0M
NIDDK NIH HHS R01 DK134580NIH HHS 5R01 DK134580
6 · The paper itself

Abstract

backgroundBenign prostatic hyperplasia (BPH) is the most common disease in aging males. BPH growth is androgen-dependent, and it appears that androgens preferentially stimulate the growth of BPH as compared to normal prostate. The mechanism of preferential androgen stimulation of BPH growth is not clear. Our previous studies suggest that primary BPH stromal cells, but not the paired normal adjacent prostate (NAP) stromal cells from the same patients, could stimulate prostatic epithelial cell proliferation in 3D co-culture. However, whether androgen regulation of prostatic stromal cells is altered in BPH nodules is not clear.

methodsPaired BPH and NAP primary stromal cells were prepared from the same patients. Early passage paired BPH and NAP primary cells were treated with androgens and/or antiandrogens for RNA-seq analysis. RNA-seq data were analyzed using principal component analysis (PCA) and functional enrichment analysis. Conditioned medium of the paired BPH and NAP primary cells in the presence or absence of androgens were used in three-dimensional (3D) culture of benign prostatic epithelial cells.

resultsRNA-seq data analysis suggests that androgen-induced gene expression in BPH primary stromal cells is heightened compared to paired NAP stromal cells. AR activation in BPH stromal cells appears to enhance cellular motility, vascular and extracellular matrix remodeling, and paracrine signaling, while simultaneously modulating cell cycle and metabolic processes. Compared to regular BPH stromal conditioned medium, conditioned medium of androgen-stimulated BPH stromal cells further enhanced prostatic epithelial cell proliferation in 3D culture. In contrast, medium of NAP stromal cell culture conditioned in the presence of androgen had no significant effect on prostatic epithelial cell proliferation in 3D culture.

conclusionsOur findings suggest that androgen stimulation of prostatic epithelial cell growth via paracrine prostatic stromal signaling is enhanced in BPH and is associated with heightened androgen-responsiveness of BPH stromal cells.

Indexed as

AndrogensProstateProstatic HyperplasiaStromal CellsCell ProliferationCells, CulturedCoculture TechniquesEpithelial CellsHumansMaleReceptors, AndrogenAndrogensReceptors, Androgen3D cultureandrogen actionbenign prostatic hyperplasia (BPH)prostatestromal‐epithelial interaction

Identifiers

PMID42669190
PMCPMC13656324

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.